Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Indian Government Rejects Abbott’s Patent Application For Second-Line ARV

India’s patent office “has rejected American drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented,” Economic Times reports (1/4). The drug under consideration was Abbott’s “Kaletra, which combines two antivirals, [lopinavir/ritonavir and] is one of the preferred second-line treatments to fight drug-resistant HIV, according to the World Health Organization, which recommends governments include it on their list of essential medicines,” Bloomberg/Businessweek writes (Narayan, 1/4).

The Scientist Examines How Nonprofit, For-Profit Pharma Groups Are Working Together To Make Drugs More Affordable For Developing Countries

“With philanthropists funneling billions of dollars into biomedical research and traditional drug discovery efforts producing fewer and fewer therapies, the line between for-profit and nonprofit life science companies is beginning to blur as both sides of the divide look for new options,” The Scientist magazine writes in an article that examines the rise in collaborations between nonprofit pharmaceutical companies and for-profit groups. “More and more for-profit enterprises are experimenting with nonprofit models, while nonprofit organizations look to incorporate for-profit business practices to stay afloat.”

Also In Global Health News: Water In The Philippines; Potential HIV Treatment; Kenyan Food Security; TB In Prisons; Ethiopian HIV Plan

Government Agencies In The Philippines Sign Sanitation Agreement To Expand Clean Water Access Filipino Interior and Local Government Secretary Jesse Robredo, Health Secretary Enrique Ona, and National Anti-Poverty Commission Secretary General Jose Eliseo Rocamora signed an agreement to honor the President’s Priority Program on Water (P3W), the Manila Bulletin reports.…

Financial Times Examines How Brazil’s State-Run Drug Sector Is Engaging In Partnerships At Home, Abroad

“Dilma Rousseff had barely been confirmed as Brazil’s new president in November when she made her first foreign visit, to Mozambique,” which “included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone – Portuguese-speaking – African partners, marking the resurgent power and growing reach of its sponsor, Brazil’s own state-led drug sector,” the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.

Recent Releases In Global Health

The Problem With A ‘Robo Budget’: In a post on “The Hill’s Congress Blog,” Senator Patrick Leahy, (D-Vt.), writes about the recent defeat of the omnibus bill, calling the passage of a continuing resolution a “robo budget” that is a “disservice.” According to Leahy: “The Omnibus would have funded global…

New York Times Reports On Gates Foundation’s Grand Challenges In Global Health Grant Program

The New York Times examines the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, which gave a total of $450 million to 43 research projects over five years. “On drawing attention to ways that lives might be saved through scientific advances, I’d give us an A,” Bill Gates, co-founder of the foundation, said of the program in an interview with the newspaper. “But I thought some would be saving lives by now, and it’ll be more like in 10 years from now,” Gates said.

Also In Global Health News: Reducing Violence Against Women; Bartering For Medical Care In Zimbabwe; Guinea Worm Eradication; Childhood Vaccination Successes, Challenges

AOL News Examines Fight Against Domestic Violence, Private Sector Role AOL News examines how the U.N. is working to include corporations in the effort to reduce domestic violence against women, which “includes beatings, rape, human trafficking and female genital mutilation.” According to the article, “more than 100 countries still don’t have laws against domestic…

Recent Releases In Global Health

Here is a sampling of blog posts analyzing the  Quadrennial Diplomacy and Development Review (QDDR) after it was released on Wednesday: Council on Foreign Relations: Weighing an Ambitious QDDR (Garrett et al., 12/16); CGD’s “Rethinking U.S. Foreign Assistance Blog”: The QDDR: Whew, It’s Done (Or Is It?) (Veillette, 12/16); State Department’s…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.